{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-25-000118","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.822229+00:00","generated_at":"2026-05-17T19:39:45.167100+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04","bullets":["Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.","Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.","Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-25-000118","json":"https://secwatch.observer/filing/0001729149-25-000118.json","markdown":"https://secwatch.observer/filing/0001729149-25-000118.md","text":"https://secwatch.observer/filing/0001729149-25-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/0001729149-25-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/vmd-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:39:45.167100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}